| Maria Bertrand, IMFT | |
|
8040 Hosbrook Rd Ste 320, Cincinnati, OH 45236 | |
| (513) 861-9797 | |
| (513) 861-3510 |
| Full Name | Maria Bertrand |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 8040 Hosbrook Rd Ste 320, Cincinnati, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043680903 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | F1700027 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Bertrand, IMFT 8040 Hosbrook Rd Ste 320, Cincinnati, OH 45236-2908 Ph: (513) 939-0300 | Maria Bertrand, IMFT 8040 Hosbrook Rd Ste 320, Cincinnati, OH 45236 Ph: (513) 861-9797 |
News Archive
Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a smart target for new therapeutics designed to treat this often deadly cancer.
About 40 percent of adults ages 40 to 74 - or 41 million people - have pre-diabetes, a condition that raises a person's risk for developing type 2 diabetes, heart disease, and stroke.
An industry-sponsored report forecasting soaring health insurance prices as a result of reform plans ignited a fight between insurers and Democrats, and doused a fragile truce between top insurance lobbyist Karen Ignagni and White House health adviser Nancy-Ann DeParle, TIME reports. After a years-long relationship and more-than-weekly phone calls despite tensions over reform plans, the recent episode "shattered the thin trust between the Administration and the insurance lobby."
Gilead Sciences, Inc. today announced that DAR-312 (DORADO-AC), a Phase III clinical trial evaluating darusentan, the company's endothelin receptor antagonist (ERA) for the treatment of resistant hypertension, did not achieve its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to placebo.
Although there have been significant advances in the provision of diabetes education since 2000, further improvements are still needed, say researchers.
› Verified 4 days ago
Dr. Elaine Willerton, PH.D. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1080 Nimitzview Dr, Ste 303, Cincinnati, OH 45230 Phone: 513-720-5642 | |
Dr. Kelly Reanee Bohnhoff, PHD, RN, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 401 E Mcmillan St, Cincinnati, OH 45206 Phone: 513-237-1413 | |
Sarah Kennedy, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 555 Cincinnati Batavia Pike, Cincinnati, OH 45244 Phone: 513-752-1555 | |
Katlyn Heath, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3665 Erie Ave, Cincinnati, OH 45208 Phone: 513-673-1848 | |
Mrs. Sandra A Metz, M.A. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2425 Adams Rd, Cincinnati, OH 45231 Phone: 513-341-6567 | |
Miss Meaggan Joanna Niesen, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5050 Madison Rd, Cincinnati, OH 45227 Phone: 513-272-2800 Fax: 513-272-2807 |